Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neuroepidemiology. 2010;34(3):163-70. doi: 10.1159/000279333. Epub 2010 Feb 2.

A prospective study of SCA3 gait ataxia described through a Markovian method.

Author information

  • 1Department of Statistics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Abstract

BACKGROUND:

Studies on the natural history of rare, chronic diseases like spinocerebellar ataxia 3 (SCA3) are hard to be done, since patients enter the study with variable disease durations and are followed up at irregular intervals.

AIMS:

Our purpose was to use all the available data to describe the progression of gait ataxia in a long-term cohort of patients with SCA3 through a markovian method.

MATERIALS AND METHODS:

SCA3 patients were recruited between 1998 and 2005 and were invited to annual neurological follow-ups until 2007. Gait ataxia was described through a mean score graph and a mean trajectory graph.

RESULTS:

We followed up 105 patients; at baseline, the mean age and disease duration were, 40.5 (SD = 12.6) and 7.7 (SD = 5.8) years, respectively. The mean time to reach stages 1, 2, 3 and 4 of gait ataxia were 3, 5.4, 10.8 and 19.4 years of disease duration. The mean score graph was unsmooth, showing several unlikely ups and downs. The mean trajectory graph produced a continuous curve.

CONCLUSION:

The markovian method described the natural history of gait ataxia without any a posteriori adjustment of data and allowed statistical comparisons between subgroups. This method will be useful in future clinical trials in this and in other chronic degenerative diseases.

2010 S. Karger AG, Basel.

PMID:
20130417
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk